2020年12月28日,Elevar Therapeutics宣布与Inceptua Group达成在欧洲分销和商业化Apealea®(紫杉醇胶束)的独家协议。Apealea已获得欧洲监管机构批准,与卡铂联用治疗首次复发的铂敏感性上皮性卵巢癌、原发性腹膜癌、输卵管癌成人患者。根据协...查看全文
$Oasmia药业(OASM)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2019-08-01 AccNo: 0001144204-19-037191 Size: 26 KB 网页链接
$Oasmia药业(OASM)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2019-07-09 AccNo: 0001144204-19-034115 Size: 40 KB 网页链接
$Oasmia药业(OASM)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2019-07-09 AccNo: 0001144204-19-034119 Size: 26 KB 网页链接
$Oasmia药业(OASM)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2019-07-02 AccNo: 0001144204-19-033574 Size: 49 KB 网页链接
$Oasmia药业(OASM)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2019-06-28 AccNo: 0001144204-19-033035 Size: 767 KB 网页链接
$Oasmia药业(OASM)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2019-06-26 AccNo: 0001144204-19-032465 Size: 22 KB 网页链接
$Oasmia药业(OASM)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2019-06-25 AccNo: 0001144204-19-032276 Size: 32 KB 网页链接
$Oasmia药业(OASM)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2019-05-20 AccNo: 0001144204-19-027215 Size: 23 KB 网页链接
$Oasmia药业(OASM)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2019-04-12 AccNo: 0001144204-19-019529 Size: 26 KB 网页链接
$Oasmia药业(OASM)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2019-04-04 AccNo: 0001144204-19-018170 Size: 31 KB 网页链接